Abstract
This chapter examines the funding of basic research primarily by government entities in the U.S. and abroad. It describes the technology transfer process that occurs at universities. Additionally, it looks at the theoretical and practical reasons for the development of bio-clusters in certain regions. Finally, it addresses the diffusion of biopharmaceutical innovations beyond these bio-clusters.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The funding of biopharmaceutical research and development
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
